Clinical Trial Update: Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity [Phase 3]

View source ↗

Summary

A Phase 3 study of GSK1358820 in patients with post-stroke lower limb spasticity has completed, and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity
• Stroke

Drugs mentioned

• GSK1358820

Snippet

Sponsor: GlaxoSmithKline | Conditions: Post-Stroke Spasticity, Cerebrovascular Accident | Phase 3 | Status: COMPLETED | Results posted: 2010-01-26